Fig. 1From: Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patientsModerate-severe ARDS prediction biomarkers in severe COVID-19 patients: NLR (0.749, 95% CI 0.624–0.850), PLR (0.660, 95% CI 0.530–0.775), PCT (0.531, 95% CI 0.401–0.658), and CRP (0.635, 95% CI 0.504–0.752)Back to article page